Identification and quantitative assessment of motor complications in Parkinson's disease using the Parkinson's KinetiGraph™

被引:0
作者
Qu, Yan [1 ]
Zhang, Tingting [2 ]
Duo, Yunyan [1 ]
Chen, Liling [1 ]
Li, Xiaohong [1 ]
机构
[1] Dalian Med Univ, Affiliated Dalian Municipal Friendship Hosp, Dept Neurol, Dalian, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 1, Dept Neurol, Dalian, Peoples R China
来源
FRONTIERS IN AGING NEUROSCIENCE | 2023年 / 15卷
关键词
Parkinson's KinetiGraph & TRADE; Parkinson's disease; motor complications; motor fluctuations; dyskinesia; HOME DIARY; FLUCTUATIONS; DYSKINESIA;
D O I
10.3389/fnagi.2023.1142268
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Introduction: Effective management and therapies for the motor complications of Parkinson's disease (PD) require appropriate clinical evaluation. The Parkinson's KinetiGraph (TM) (PKG) is a wearable biosensor system that can record the motion characteristics of PD objectively and remotely.Objective: The study aims to investigate the value of PKG in identifying and quantitatively assessing motor complications including motor fluctuations and dyskinesia in the Chinese PD population, as well as the correlation with the clinical scale assessments.Methods: Eighty-four subjects with PD were recruited and continuously wore the PKG for 7 days. Reports with 7-day output data were provided by the manufacturer, including the fluctuation scores (FS) and dyskinesia scores (DKS). Specialists in movement disorders used the Movement Disorder Society-Unified Parkinson's Disease Rating Scale-IV (MDS-UPDRS IV), the wearing-off questionnaire 9 (WOQ-9), and the unified dyskinesia rating scale (UDysRS) for the clinical assessment of motor complications. Spearman correlation analyses were used to evaluate the correlation between the FS and DKS recorded by the PKG and the clinical scale assessment results. Receiver operating characteristic (ROC) curves were generated to analyze the sensitivity and specificity of the FS and DKS scores in the identification of PD motor complications.Results: The FS was significantly positively correlated with the MDS-UPDRS IV motor fluctuation (items 4.3-4.5) scores (r = 0.645, p < 0.001). ROC curve analysis showed a maximum FS cut-off value of 7.5 to identify motor fluctuation, with a sensitivity of 74.3% and specificity of 87.8%. The DKS was significantly positively correlated with the UDysRS total score (r = 0.629, p < 0.001) and the UDysRS III score (r = 0.634, p < 0.001). ROC curve analysis showed that the maximum DKS cut-off value for the diagnosis of dyskinesia was 0.7, with a sensitivity of 83.3% and a specificity of 83.3%.Conclusion: The PKG assessment of motor complications in the PD population analyzed in this study has a significant correlation with the clinical scale assessment, high sensitivity, and high specificity. Compared with clinical evaluations, PKG can objectively, quantitatively, and remotely identify and assess motor complications in PD, providing a good objective recording for managing motor complications.
引用
收藏
页数:9
相关论文
共 50 条
[31]   The role of Personal KinetiGraph™ fluctuator score in quantifying the progression of motor fluctuations in Parkinson's disease [J].
Tan, Echo E. ;
Hogg, Elliot James ;
Tagliati, Michele .
FUNCTIONAL NEUROLOGY, 2019, 34 (01) :21-28
[32]   Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease [J].
Memedi, Mevludin ;
Sadikov, Aleksander ;
Groznik, Vida ;
Zabkar, Jure ;
Mozina, Martin ;
Bergquist, Filip ;
Johansson, Anders ;
Haubenberger, Dietrich ;
Nyholm, Dag .
SENSORS, 2015, 15 (09) :23727-23744
[33]   Impact of the motor complications of Parkinson's disease on the quality of life [J].
Chapuis, S ;
Ouchchane, L ;
Metz, O ;
Gerbaud, L ;
Durif, F .
MOVEMENT DISORDERS, 2005, 20 (02) :224-230
[34]   Therapeutic strategies to prevent motor complications in Parkinson's disease [J].
Kieburtz, Karl .
JOURNAL OF NEUROLOGY, 2008, 255 (Suppl 4) :42-45
[35]   Medical Management and Prevention of Motor Complications in Parkinson’s Disease [J].
Stephen D. Aradi ;
Robert A. Hauser .
Neurotherapeutics, 2020, 17 :1339-1365
[36]   Medical Management and Prevention of Motor Complications in Parkinson's Disease [J].
Aradi, Stephen D. ;
Hauser, Robert A. .
NEUROTHERAPEUTICS, 2020, 17 (04) :1339-1365
[37]   Motor complications of chronic levodopa therapy in Parkinson's disease [J].
Miyawaki, E ;
Lyons, K ;
Pahwa, R ;
Troster, AI ;
Hubble, J ;
Smith, D ;
Busenbark, K ;
McGuire, D ;
Michalek, D ;
Koller, WC .
CLINICAL NEUROPHARMACOLOGY, 1997, 20 (06) :523-530
[38]   Therapeutic strategies to prevent motor complications in Parkinson’s disease [J].
Karl Kieburtz .
Journal of Neurology, 2008, 255 :42-45
[39]   Treatment of motor symptoms in advanced Parkinson's disease: A practical approach [J].
Maranis, S. ;
Tsouli, S. ;
Konitsiotis, S. .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (08) :1795-1807
[40]   Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease [J].
Antonini, Angelo ;
Jost, Wolfgang H. .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 :S5-S9